DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy
Kevin Chih‐Yang Huang(China Medical University), K. S. Clifford Chao(The University of Texas MD Anderson Cancer Center)
Cited by 41
Related Papers
Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2004|3.2k
Decitabine Augments Chemotherapy-Induced PD-L1 Upregulation for PD-L1 Blockade in Colorectal Cancer
|Cancers|2020|115
Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade
|Cell Death and Disease|2022|47
Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation
|Cancer Immunology Immunotherapy|2023|30